Cargando…
The GHS-R Blocker D-[Lys3] GHRP-6 Serves as CCR5 Chemokine Receptor Antagonist
[D-Lys3]-Growth Hormone Releasing Peptide-6 (DLS) is widely utilized in vivo and in vitro as a selective ghrelin receptor (GHS-R) antagonist. This antagonist is one of the most common antagonists utilized in vivo to block GHS-R function and activity. Here, we found that DLS also has the ability to m...
Autores principales: | Patel, Kalpesh, Dixit, Vishwa Deep, Lee, Jun Ho, Kim, Jie Wan, Schaffer, Eric M., Nguyen, Dzung, Taub, Dennis D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222091/ https://www.ncbi.nlm.nih.gov/pubmed/22211090 |
Ejemplares similares
-
Identification of Ghrelin Receptor Blocker, D-[Lys3] GHRP-6 as a CXCR4 Receptor Antagonist
por: Patel, Kalpesh, et al.
Publicado: (2011) -
Age-associated alterations in CXCL1 chemokine expression by murine B cells
por: Hu, Lina, et al.
Publicado: (2004) -
Inhibition of Ghrelin Activity by Receptor Antagonist [d-Lys-3] GHRP-6 Attenuates Alcohol-Induced Hepatic Steatosis by Regulating Hepatic Lipid Metabolism
por: Rasineni, Karuna, et al.
Publicado: (2019) -
Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes
por: Dawson, Harry D, et al.
Publicado: (2006) -
Screening of chemokine receptor CCR4 antagonists by capillary zone electrophoresis
por: Sun, Zhe, et al.
Publicado: (2011)